The big question in many providers' minds is, can Paragon make the jump to the large-hospital segment?
OREM, UT, October 22, 2013 /24-7PressRelease/
-- Lower costs and a history of development are the keys to McKesson Paragon's continued growth in larger hospitals despite significant gaps in clinical functionality. In a recent KLAS report entitled McKesson Paragon 2013: Balancing the Risk and the Reward
, healthcare professionals from 44 hospitals explained where they have confidence and where they have concerns regarding McKesson Paragon's ability to deliver in large hospital settings.
"The big question in many providers' minds is, can Paragon make the jump to the large-hospital segment?" said Coray Tate, report author. "Most of the providers we interviewed are optimistic that they can even though there is a pretty big functionality gap right now. This is a great example of how a strong history of development can give vendors a little breathing room as they expand their products into new markets."
The report examines Paragon across multiple criteria including performance, clinical functionality, cost of ownership and migration from Horizon. The hospitals interviewed included representation from all hospital size segments.
For further details, visit KLAS online at www.KLASresearch.com/reports
and view McKesson Paragon 2013: Balancing the Risk and the Reward
. The report is available to healthcare providers and vendors. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey about one of their current vendors.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch